TScan Therapeutics, Inc. (TCRX) stock
TCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/3089% below fair value
$0.15+0.00 (+2.24%)
Close on Nov 20, 2026Market cap $9.89MP/E –Yield –
TScan Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
TScan Therapeutics's market cap was $24.11M on Nov 11, 2026, against $141.55M a year earlier. Over the last 4 years it ranged from $11.02M to $710.03M, with a median of $140.22M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $24.11M | -81.1% |
| 2025 | Dec 31, 2025 | $127.52M | -60.3% |
| 2024 | Dec 31, 2024 | $320.92M | +15.7% |
| 2023 | Dec 29, 2023 | $277.42M | +879.4% |
| 2022 | Jan 31, 2022 | $28.33M | +7.3% |
| 2021 | Dec 31, 2021 | $26.39M | – |
See a number that looks wrong?